SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-24-002971
Filing Date
2024-12-17
Accepted
2024-12-17 17:42:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G sc13ga107422pirs_12172024.htm SC 13G/A 282442
  Complete submission text file 0000921895-24-002971.txt   284392
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087
Business Address 125 STRAFFORD AVE SUITE 360 WAYNE PA 19087 (484) 253-1461
PALVELLA THERAPEUTICS, INC. (Subject) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88917 | Film No.: 241556953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)